Imaging biomarkers serve as important end points for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies.
Imaging Biomarkers in Clinical Trials
Apr 24th, 2014Apr 25th, 2014
Latest in Home
PSMA-PET scans guide LDR brachytherapy in prostate cancer
October 5, 2026
Half of false-negative DBT exams are missed cancers
October 5, 2026















